BIRMF (Biorem) Beta: 0.8528 (As of Jul. 03, 2026)


BIRMF Biorem Inc BIRMF
88 GF Score
Price $2.19
GF Value $1.95
Valuation Modestly Overvalued
View Full Analysis

What is Biorem Beta?

Biorem BIRMF +0.39% 88 Beta is 0.8528 as of Jul. 03, 2026. GuruFocus rates BIRMF with a GF Score™ of 88/100 and a GF Value™ of $1.95 (Modestly Overvalued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-03), Biorem's Beta is 0.8528.


Biorem  (OTCPK:BIRMF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Biorem Beta Related Terms


Biorem Beta Historical Data

* Premium members only.

The historical data trend for Biorem's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem Beta Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 0.86 0.02 0.29 0.42

Biorem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.40 0.48 0.42 0.51

BIRMF vs VLTO, ZWS, CECO: Beta Comparison

For the Pollution & Treatment Controls subindustry, Biorem's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biorem Beta vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Biorem's Beta distribution charts can be found below:

* The bar in red indicates where Biorem's Beta falls into.


BIRMF
88GF Score
Biorem Inc BIRMF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8528 mean?
Biorem (BIRMF) has a Beta of 0.8528 as of Jul. 03, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Biorem and its competitors.
Is Biorem's Beta too high?
Biorem's current Beta is 0.8528. Overall, Biorem has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Beta compare to VLTO and ZWS?
Biorem's Beta of 0.8528 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Industrial Products company?
A good Beta depends on the Industrial Products industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Biorem and its competitors. Biorem's current Beta is 0.8528. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.95, compared to a current price of $2.19 — trading 12.3% above its estimated fair value. The current Beta is 0.8528. Biorem's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Biorem (BIRMF), the current Beta is 0.8528 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (BIRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of $2.19 is trading 12.3% above its estimated GF Value™ of $1.95. GuruFocus considers Biorem to be Modestly Overvalued.

Key valuation signals for BIRMF:

  • Beta: 0.8528
  • GF Value™: $1.95 vs. price of $2.19 (12.3% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biorem Business Description

Other Exchanges R6D:GermanyBRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
88GF Score

Get the complete analysis for BIRMF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.19
Price
$1.95
GF Value